The epidemiology of triple-negative breast cancer, including race
about
Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerEpidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestryMolecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinomaBreastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysisBreast cancer subtypes and previously established genetic risk factors: a bayesian approachBreast cancer pathology, receptor status, and patterns of metastasis in a rural Appalachian populationTriple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.Reproductive risk factors and breast cancer subtypes: a review of the literature.Hypothesized role of pregnancy hormones on HER2+ breast tumor development.Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort studyAssociation between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis.Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis.Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer ProgressionActive smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesBreast feeding, parity and breast cancer subtypes in a Spanish cohortObesity-mediated regulation of HGF/c-Met is associated with reduced basal-like breast cancer latency in parous mice.Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American womenReproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 statusBody size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women.Management options in triple-negative breast cancerParity and lactation in relation to estrogen receptor negative breast cancer in African American women.Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010.Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.Triple-Negative Breast Cancer: Clinical and Histological Correlations.Cancer immunology--analysis of host and tumor factors for personalized medicine.Triple-negative breast cancer: adjuvant therapeutic options.Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study.Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.Early-Life Socioeconomic Status and the Prevalence of Breast Cancer in Later Life.Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
P2860
Q26744566-03F2E8EB-756F-4F64-9952-C0CDFCA13731Q27011535-08A65AD6-DF3A-482C-AB4F-D2BC1361514DQ28076106-CF22F49C-AAE9-49BE-8C16-627720811E59Q28085555-F3A281A9-BD29-4436-A4E0-5DDBB6066ADBQ28397311-498E8403-2068-4499-BE12-44C0BF30E521Q29006708-5551464E-611C-42C3-81C8-EC56F51085BDQ31102636-D5420795-2656-44F6-A87C-9B955EC428DFQ33596695-89C5DFFE-70BA-4E80-A83F-A6FF4AF37215Q33618393-D45CC4FB-4080-40FE-B719-10F73FA3D290Q33632008-591A22DD-2EBE-4524-9253-852E1D25E9DCQ33745434-0620A568-CE13-4E2F-99DE-910BE1B97EBCQ33758934-0E851676-D698-4D56-8265-DFE4C41747A4Q33857861-6D54BF72-D4B3-475B-9753-194EE96238E1Q33859673-81C130DC-C507-47C0-8697-954D761690DDQ33859809-029E19AE-2A99-4C58-A0BE-93A08B5970A8Q33874970-69C90852-54CF-417D-AA54-79F6F2E07260Q34119028-5463BCBC-3C25-4BD4-88C8-5C36D742C648Q34336498-F6BEB23A-A1EC-4683-B991-3C83ABEB73E4Q34420979-69FD432E-EE57-4BBD-BDDC-907BD496B000Q34590295-8093B725-6784-4A0F-8F62-AB877C5307B3Q34619821-2CA997AE-D6C0-4BB0-AFE1-AFC0F1864A1DQ34677207-3B2E444C-CC09-487C-88E2-1D67F6187275Q34705321-0ADAEC6D-0222-45A0-B1CA-99AF14083411Q34722266-AA5742D5-B066-4FCB-8CF5-4BE61695BD8AQ34736954-27A16968-A1FD-4A73-A9C3-B847751DE640Q35000223-2AAE44D3-1ED4-4B96-9CAE-CC32D23B2EC5Q35155460-824E29FC-77AF-432D-A6D2-377753504813Q35229557-83E69465-06A3-4467-ADED-CA02CB4AA281Q35437586-34710B38-C669-4048-B1EC-8168B507B965Q35558962-FD3C739A-6B58-4FBB-BE7E-24E6604BED3BQ35565644-ED287271-4CD0-48C5-B81B-8EF01E5A84EFQ35573190-FDDEDD19-74D2-4AFC-8163-990DEE53336BQ35576252-093C3454-7449-45DB-A409-BCF6B04B2A40Q35583180-E111F7C8-4809-42A9-B8E8-7AF2AE490E8FQ35692146-10F83E95-1E21-4AF3-913E-9056CE97842DQ35694329-1588946E-7CAA-4402-82A5-8EC41E789A54Q35918620-8F3FFB87-04A1-4E47-A020-147715B96B4DQ35928943-9D70C1E6-9555-4A91-882E-A474C5A51288Q36191310-4C469F20-8D14-40EE-AD7B-A40BD7A34B57Q36272043-53627406-D2FD-46C1-85A3-A2708F1ECBE6
P2860
The epidemiology of triple-negative breast cancer, including race
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The epidemiology of triple-negative breast cancer, including race
@ast
The epidemiology of triple-negative breast cancer, including race
@en
The epidemiology of triple-negative breast cancer, including race
@en-gb
The epidemiology of triple-negative breast cancer, including race
@nl
type
label
The epidemiology of triple-negative breast cancer, including race
@ast
The epidemiology of triple-negative breast cancer, including race
@en
The epidemiology of triple-negative breast cancer, including race
@en-gb
The epidemiology of triple-negative breast cancer, including race
@nl
prefLabel
The epidemiology of triple-negative breast cancer, including race
@ast
The epidemiology of triple-negative breast cancer, including race
@en
The epidemiology of triple-negative breast cancer, including race
@en-gb
The epidemiology of triple-negative breast cancer, including race
@nl
P2093
P2860
P3181
P1476
The epidemiology of triple-negative breast cancer, including race
@en
P2093
Elaine W Flagg
J William Eley
Jonathan M Liff
Katrina F Trivers
Mary Jo Lund
Peggy L Porter
Ralph J Coates
P2860
P2888
P304
P3181
P356
10.1007/S10552-009-9331-1
P407
P577
2009-09-01T00:00:00Z
P6179
1014892537